Dow Inc. Files 8-K with Financial and Regulatory Updates

Ticker: DOW · Form: 8-K · Filed: May 16, 2024 · CIK: 1751788

Sentiment: neutral

Topics: 8-K, regulatory-disclosure, financial-statements

TL;DR

Dow Inc. filed an 8-K on 5/16/24 for financial and regulatory updates.

AI Summary

Dow Inc. filed an 8-K on May 16, 2024, to disclose information regarding Regulation FD and financial statements. The filing includes details about the company's structure, including its former names Dow Holdings Inc. and The Dow Chemical Co. /DE/, and its primary business in plastics and synthetic resins.

Why It Matters

This filing provides essential updates on Dow Inc.'s financial reporting and regulatory compliance, which are crucial for investors to assess the company's current standing and future outlook.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial and regulatory information, not indicating any immediate operational or financial distress.

Key Players & Entities

FAQ

What is the primary business of Dow Inc. as indicated in the filing?

Dow Inc.'s primary business is in PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS, with SIC code 2821.

When was this 8-K filing submitted?

The 8-K filing was submitted on 20240516.

What are the former names of Dow Inc. mentioned in the filing?

The filing mentions Dow Holdings Inc. (name change 20180831) and The Dow Chemical Co. /DE/.

What is Dow Inc.'s fiscal year end?

Dow Inc.'s fiscal year ends on 1231.

What is the business address and phone number for Dow Inc.?

The business address is 2211 H.H. DOW WAY, MIDLAND, MI 48674, and the business phone number is 9896361000.

Filing Stats: 1,635 words · 7 min read · ~5 pages · Grade level 12 · Accepted 2024-05-16 06:05:37

Key Financial Figures

Filing Documents

From the Filing

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2024 ( May 16, 2024 ) Commission Exact Name of Registrant as Specified in its Charter, I.R.S. Employer File Number Principal Office Address and Telephone Number Organization Identification No. 001-38646 Dow Inc. Delaware 30-1128146 2211 H.H. Dow Way , Midland , MI 48674 ( 989 ) 636-1000 001-03433 The Dow Chemical Company Delaware 38-1285128 2211 H.H. Dow Way , Midland , MI 48674 ( 989 ) 636-1000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Registrant Title of each class Trading Symbol(s) Name of each exchange on which registered Dow Inc. Common Stock, par value $0.01 per share DOW New York Stock Exchange The Dow Chemical Company 0.500% Notes due March 15, 2027 DOW/27 New York Stock Exchange The Dow Chemical Company 1.125% Notes due March 15, 2032 DOW/32 New York Stock Exchange The Dow Chemical Company 1.875% Notes due March 15, 2040 DOW/40 New York Stock Exchange The Dow Chemical Company 4.625% Notes due October 1, 2044 DOW/44 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Dow Inc. The Dow Chemical Company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Dow Inc. The Dow Chemical Company Section 7 - Regulation FD Item7.01 Regulation FD Disclosure. On May 16, 2024, beginning at 10:00 a.m. Eastern Time, Dow Inc. ("Dow") will hold a publicly available webcast event for investors and the general public ("Investor Day"). At Investor Day, Dow will provide presentations discussing its strategy, market-led growth drivers, financial priorities, and Decarbonize & Grow and Transform the Waste strategies, among other topics. These slide presentations are attached as Exhibit 99.1 to this report and incorporated herein by reference. On May 16, 2024, Dow will issue the press releases attached as Exhibits 99.2, 99.3, 99.4, 99.5, 99.6, 99.7 and 99.8 to this report and incorporated herein by reference, announcing various strategic initiatives that will be discussed during Investor Day. To view the webcast, presentations, and press releases, visit the Investor page on corporate.dow.com. A replay and transcript will also be available within 48 hours following the event. The presentations contain "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would" and similar expressions, and variations or negatives of these words or phrases. Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow's control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow's products; Dow's expenses, future revenues and profitability; any global and regional economic impacts of a pandemic or other public health-related risks and events on Dow's business; any sanctions, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflicts between Russia and Ukraine and in the Middle East; capital requirements and need for and availability of financing; unexpected barr

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing